Skip to main content
. 2010 Oct 6;18(1):50–58. doi: 10.1128/CVI.00314-10

TABLE 2.

Rectal temperatures (°C) in surviving piglets at different intervals after challenge with H. parasuis

Expt group (n)a Mean temp (°C) ± SD at various intervals after challenge (n)b
0 h 24 h 48 h 72 h 144 h
Control (4) 38.1 ± 0.33 (4) 41.0 ± 0.70A (2) 41.2 ± 0.49A (2) — (0) — (0)
rTbpA (6) 39.0 ± 0.40 (6) 40.1 ± 0.78BC (6) 39.7 ± 0.31D (4) 39.4 ± 0.55 (2) 39.2 ± 0.17 (2)
rTbpB (5) 38.4 ± 0.27 (5) 39.6 ± 1.02BD (5) 39.7 ± 1.07BE (5) 39.1 (1) 39.2 (1)
NPAPTM (6) 39.4 ± 0.31 (6) 39.4 ± 0.31E (6) 39.0 ± 0.22E (6) 38.9 ± 0.31 (6) 39.3 ± 0.17 (6)
NPAPTCp (6) 39.4 ± 0.27 (6) 39.2 ± 0.15E (6) 39.2 ± 0.36E (6) 38.8 ± 0.21 (6) 39.2 ± 0.10 (6)
PG (6) 38.7 ± 0.62 (6) 39.2 ± 0.19E (6) 39.0 ± 0.16E (6) 39.1 ± 0.53 (6) 39.4 ± 0.07 (6)
a

Experimental groups: Control, no vaccine; rTbpA, vaccine containing rTbpA plus Montanide IMS 2215 VG PR in a 1:4 ratio; rTbpB, vaccine containing rTbpA plus Montanide IMS 2215 VG PR in a 1:4 ratio; NPAPTM, native proteins with affinity for porcine-transferrin plus Montanide IMS 2215 VG PR in a 1:4 ratio; NPAPTCp, native proteins with affinity for porcine-transferrin plus neuraminidase from Clostridium perfringens (100 mU/ml); PG, Porcilis Glässer (Intervet). n, Number of animals per group.

b

The numbers of surviving piglets at each time point (n) are indicated in parentheses. Superscript capital letters indicate significant differences as follows: A, P < 0.0005 from result at 0 h (challenge); B, P < 0.005 from result at 0 h (challenge); C, P < 0.05 compared to control group; D, P < 0.005 compared to control group; and E, P < 0.0005 compared to control group.